Blackstone Group said on Friday it had agreed to buy Japanese drug maker Ayumi Pharmaceutical Corp, a deal one person said was worth around $1 billion. The deal marks the first one in Japan by the U.S. private equity...
Insys says Lazard hired to advise on options, in talks to divest Subsys
Insys Therapeutics Inc said it tapped Lazard to advise the drugmaker on its plans to explore strategic options and is in talks to divest its fentanyl sublingual spray Subsys, sending the company’s shares down 15 percent...
Suven eyes acquisition of Rising Pharmaceuticals’ assets
Suven Life Sciences has entered into a stalking-horse asset purchase agreement to buy the assets of Aceto Corporation’s Rising Pharmaceuticals and Rising subsidiaries through its joint venture partner Shore Suven...
Novartis has no plans to sell Sandoz: chairman
Swiss drugmaker Novartis has no plans to sell all or parts of its Sandoz generics business, Chairman Joerg Reinhardt said in a newspaper interview, saying it was keeping its options open. “Sales are not planned at the...
OxyContin maker Purdue Pharma exploring bankruptcy – sources
OxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address potentially significant liabilities from roughly 2,000 lawsuits alleging the drugmaker contributed to the deadly opioid crisis sweeping the...
Orchid Pharma insolvency case: NCLAT notice to Ingen Capital directors
The National Company Law Appellate Tribunal (NCLAT) has directed Ingen Capital directors Umesh Bhatia and Harish Bhatia to reply in three weeks on why action should not be taken against them on not paying the Rs 1,000...
Top Bristol-Myers shareholder comes out against $74 billion Celgene deal
Bristol-Myers Squibb Co’s top shareholder Wellington Management said on Wednesday it does not support the U.S. drugmaker’s $74 billion deal to buy biotech Celgene Corp, imperiling what would be the largest...
Germany’s Merck makes $5.9 bln counterbid for Versum
German drugs and lab supplies maker Merck KGaA offered $5.9 billion, including debt, for Versum Materials, in a cash deal that tops an offer from U.S. rival Entegris, as both seek to boost their electrochemicals...
Brazil’s largest pharmacy chain Raia Drogasil buys rival from CVS
Brazil’s largest pharmacy chain Raia Drogasil SA said on Tuesday it would fully acquire Drogaria Onofre, a rival controlled by CVS Health Corp. Raia Drogasil said in a statement it had reached an agreement with CCI...
Cipla to acquire 11.71% stake in Wellthy Therapeutics
Drug major Cipla NSE 0.14 %Monday said it has inked a pact to acquire 11.71 per cent stake in Wellthy Therapeutics. Goldencross Pharma, a wholly-owned subsidiary of Cipla, has inked an agreement to acquire the minority...
Glenmark Pharma to spin off innovation business into a new US company
The board of Glenmark Pharmaceuticals has approved the spinoff of its innovation business into a new company in the US. Setting up of the new company will provide an enhanced focus to the innovation business and help...
Aurobindo acquires Apotex’s commercial operations in 5 European countries
Aurobindo Pharma on Monday said it has completed the Euro 74-million deal to acquire Apotex’s commercial operations and certain supporting infrastructure in five European countries. The company had inked a binding...
